Scirrhous changes in dysplastic nodules do not indicate high-grade status

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 6, 2003, Pages 660-665

  An, Hee Jung ^a,c   Illei, Peter ^b   Diflo, Thomas ^b   John, Devon ^b   Morgan, Glyn ^b   Teperman, Lewis ^b   Theise, Neil ^b  

^a CHA University   (South Korea)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pundang CHA Hospital   (South Korea)

Author keywords

Dysplastic nodule; Pericellular type; Scirrhous change; Stellate type

Indexed keywords

HEMATOXYLIN; KI 67 ANTIGEN; RETICULIN;

ANTIBODY LABELING; ARTICLE; CELL KINETICS; CELL STRUCTURE; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER ISCHEMIA; LIVER NODULE; LIVER REGENERATION; MALLORY BODY; PORTAL VEIN; PRECANCER; PRIORITY JOURNAL; STAINING;

EID: 0037713323     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03052.x     Document Type: Article

References (27)

1. Arakawa M, Sugihara S, Kenmochi K et al. Small mass lesions in cirrhosis: Transition from benign adenomatous hyperplasia to hepatocellular carcinoma? J. Gastroenterol. Hepatol. 1986; 1: 3-14.
2. Dhillon A, Colombari R, Savage K et al. An immunohistochemical study of the blood vessels within primary hepatocellular tumors. Liver 1992; 12: 311-18.
3. Edmondson HA. Benign epithelial tumors and tumor like lesions of the liver. In: Okuda K, Peters RI, eds. Hepatocellular Carcinoma. New York: Wiley, 1976; 309-30.
4. Ferrell LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am. J. Surg. Pathol. 1993; 17: 1113-23.
5. Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H. Macroregenerative nodule of the liver: a clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 1988; 61: 99-105.
6. Gibson JB & Sobin LH. Histologic Typing of Tumors of the Liver, Biliary Tract and Pancreas. International Histological Classification of the Tumors, No. 20. Geneva, Switzerland: World Health Organization, 1978; 30.
7. Grigioni W, D'Errico A, Bacci F et al. Primary liver neoplasms: evaluation of proliferative index using MoAb Ki-67. J. Pathol. 1989; 158: 23-9.
8. Hoso M, Nakanuma Y. Cytophotometric DNA analysis of adenomatous hyperplasia in cirrhotic livers. Virchows Arch. (A) 1991; 418: 401-4.
9. Hytiroglou P, Theise ND, Schwartz M, Mor E, Miller C, Thung SN. Macroregenerative nodules in a series of adult cirrhotic liver explants: Issues of classification and nomenclature. Hepatology 1995; 21: 703-8.
10. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
11. Le Bail B, Bellennee G, Bernard P-H et al. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 lesions in the cirrhotic explants of 10 adult French patients. Hum. Pathol. 1995; 26: 897-906.
12. Nakanuma Y, Ohta G. Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 1985; 55: 2400-4.
13. Nakanuma Y, Ohta G. Expression of Mallory bodies in hepatocellular carcinoma in man and its significance. Cancer 1987; 57: 81-6.
14. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-38.
15. Nakanuma Y, Terada T, Terasaki S et al. Atypical adenomatous hyperplasia in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion? Hepatology 1990; 17: 27-35.
16. Orsatti G, Theise ND, ThungSN, Paronetto F. DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature. Hepatology 1993; 17: 621-7.
17. Park YN, Yan CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND. Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am. J. Surg. Pathol. 1998; 22: 656-62.
18. Shinagawa T, Ohito M, Kimura K et al. Diagnosis and clinical features of amll hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study with 51 patients. Gastroenterology 1984; 86: 495-502.
19. Theise ND. Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations. Sem. Liver Dis. 1995; 15: 360-71.
20. Theise ND, Marcelin K, Goldfischer M, Hytiroglou P, Ferrell L, Thung SN. Low proliferative activity in macroregenerative nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver 1996; 16: 134-9.
21. Theise ND, Schwartz M, Miller C. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 1992; 16: 949-55.
22. Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 1989; 10: 851-4.
23. Terada T, Nakanuma Y. Cell proliferative activity of adenomatous hyperplasia in the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen. Cancer 1992; 70: 591-8.
24. Terada T, Hoso M, Nakanuma Y. Mallory body clustering in adenomatous hyperplasia in human cirrhotic livers; report of four cases. Hum. Pathol. 1989; 20: 886-90.
25. Terada T, Ueda K, Nakanuma Y. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers. Virchows Arch. (A) 1993; 422: 381-8.
26. Terasaki S, Terada T, Nakanuma Y et al. Argyrophilic nucleolar organizer regions and alpha-fetoprotein in adenmatous hyperplasia in human cirrhotic livers. Am. J. Clin. Pathol. 1991; 95: 850-7.
27. Wada K, Kondo F, Kondo Y. Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study. Hepatology 1988; 8: 1684-8.